SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Joe NYC who wrote (211408)11/11/2004 3:06:56 AM
From: Tenchusatsu  Read Replies (1) | Respond to of 1584002
 
Joe, We would be closer to the free market if re-importation is allowed.

Drug companies will react by not selling to Canada anymore. We'll end up back at square one, except with a bigger public outcry against those "evil" drug companies.

As far as price controls, (foreign and domestic), at some price point the drug companies will just say "no".

You're probably right about that. The drug companies probably see the handwriting on the wall and will pressure Canada to lift or ease up on price controls.

Tenchusatsu



To: Joe NYC who wrote (211408)11/11/2004 10:30:20 AM
From: Peter Dierks  Respond to of 1584002
 
Freer markets allocate more efficiently. Reimportation, or some other mechanism to get the rest of the first world to pay for drug research would benefit US drug consumers. Why should we pay $100 a dose and foreigners pay $10?

You are right about price controls. Most of the drug companies are true multi-nationals. If the US restricts them, they will move their offices overseas. Regulation is rarely called for.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News